Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Actualizado 27/06/2024 - 12:00 Reviewed Jue, 27/06/2024 - 12:00

Appendix A: Pediatric Antiretroviral Drug Information

Overview

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

Tenofovir alafenamide

Tenofovir disoproxil fumarate

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

Protease Inhibitors (PIs)

Lopinavir/Ritonavir

Entry and Fusion Inhibitors

Capsid Inhibitors

Integrase Inhibitors (INSTIs)

Pharmacokinetic Enhancers

Fixed-Dose Combinations

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

Appendix A, Table 2. Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents

Archived Drugs

Download Guidelines

Section Only PDF (27.06 KB)
Full Guideline PDF (6.34 MB)
Recommendations Only PDF (227.38 KB)
Tables Only PDF (1.03 MB)
Drug Tables Only PDF (2.38 MB)